India Large Molecule Bioanalytical Testing Services Market Size & Outlook

The large molecule bioanalytical testing services market in India is expected to reach a projected revenue of US$ 58.4 million by 2030. A compound annual growth rate of 10.3% is expected of India large molecule bioanalytical testing services market from 2022 to 2030.

Revenue, 2021 (US$M)
$24.2
Forecast, 2030 (US$M)
$58.4
CAGR, 2022 - 2030
10.3%
Report Coverage
India

India large molecule bioanalytical testing services market, 2018-2030 (US$M)

India

Related Markets

India large molecule bioanalytical testing services market highlights

  • The India large molecule bioanalytical testing services market generated a revenue of USD 24.2 million in 2021 and is expected to reach USD 58.4 million by 2030.
  • The India market is expected to grow at a CAGR of 10.3% from 2022 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2021.
  • Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.


Large molecule bioanalytical testing services market data book summary

Market revenue in 2021USD 24.2 million
Market revenue in 2030USD 58.4 million
Growth rate10.3% (CAGR from 2021 to 2030)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPreclinical, Clinical
Key market players worldwideLabcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, India accounted for 1.5% of the global large molecule bioanalytical testing services market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China large molecule bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 58.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Large Molecule Bioanalytical Testing Services Market Scope

Large molecule bioanalytical testing services market segmentation & scope
With Antibody
Without Antibody (ELISA Based Assay)
Clinical
Pharmacokinetics
ADA
Others
ADME
PD
Bioavailability
Bioequivalence
Other Tests
Oncology
Infectious Diseases
Cardiology
Neurology
Others
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)

Large Molecule Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website

India large molecule bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 66.12% in 2021. Horizon Databook has segmented the India large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Improvement in number of clinical trials in the country will boost demand for large-scale bioanalytical testing. For instance, India conducted 27,638 clinical trials between 1999 and 2019, according to WHO’s ICTRP. This accounted for 5.27% of total clinical trials conducted globally in the same period.

Furthermore, according to the World Bank, the current healthcare expenditure of India was 3.5% of its GDP in 2018. However, Indian government has more than doubled its healthcare spending for the fiscal year 2020- 2021 in the union budget, with the intention of boosting the healthcare sector.

Such favorable government initiatives are expected to propel market growth. According to India Brand Equity Foundation (IBEF), Indian pharma companies invested 8.8% of their sales revenue on R&D in 2018. The rising pharmaceutical R&D investment in the country will also boost growth.

Reasons to subscribe to India large molecule bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India large molecule bioanalytical testing services market databook

  • Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into India large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

India Large Molecule Bioanalytical Testing Services Market Outlook Share, 2021 & 2030 (US$M)

India large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more